Trevena Inc

0.00 (+0.46%)
: $0.40 -0.02 (-3.74%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)68.61M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.36 Million
Adjusted EPS-$0.10
See more estimates
10-Day MA$0.42
50-Day MA$0.33
200-Day MA$0.62
See more pivots

Trevena Inc Stock, NASDAQ:TRVN

955 Chesterbrook Boulevard, Suite 110, Chesterbrook, Pennsylvania 19087
United States of America
Phone: +1.610.354.8840
Number of Employees: 43


Trevena, Inc. engages in the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.